Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedA new Revision: v3.5.3 tag was added to the page, indicating an update from the previous revision (v3.5.2).SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedSite revision indicator updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check57 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision: v3.4.2 was added. The funding-status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check93 days agoChange DetectedA government funding lapse notice is now displayed on the page, and the site revision tag has been updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.